// Real-Time Intelligence Feed

Financial Intelligence.
Real-Time.

SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.

18,992
Stories Indexed
Live
Feed Status
6
Data Sources
AllEarningsFDAM&AInsider TradingRegulatoryOfferingLeadershipRestructuringDividendInstitutional HoldingsBankruptcy
ALL STORIES · 18,992 results Live
FDA USAntibiotics, Jun 22 — 0.00

FDA Approves AUGMENTIN ES-600 — USAntibiotics, LLC

**USAntibiotics, LLC** has secured FDA clearance for Augmentin ES-600 (amoxicillin and clavulanate potassium), reinforcing the company's position in the pediatric antibiotics marke…

FDA SpecGx May 31 — 0.00

FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — SpecGx LLC

SpecGx LLC has secured an FDA approval for the generic version of Acetaminophen and Codeine Phosphate oral tablets, expected to expand its current portfolio and enhance its footpri…

FDA Teva Mar 21 — 0.00

FDA Approves TREXALL — Teva Women's Health LLC

# FDA Approves Teva Women's Health's Oral Methotrexate Sodium Product Teva Women's Health LLC received FDA approval for TREXALL (methotrexate sodium) oral formulation, expanding t…

FDA RISING Dec 19 — 0.00

FDA Approves Unknown Drug — RISING

On December 19, 2000, Rising received FDA approval for ANDA075725, marking a significant commercial entry into the market. This approval is expected to bolster the company’s revenu…

FDA Strides Dec 1 — 0.00

FDA Approves DOXYCYCLINE — Strides Pharma Science Limited

# FDA Approves Doxycycline ANDA for Strides Pharma Science Limited Strides Pharma Science Limited has received FDA approval for its abbreviated new drug application (ANDA065055) f…

FDA Kenvue Nov 30 — 0.00

FDA Approves IMODIUM MULTI-SYMPTOM RELIEF — Kenvue Brands LLC

# FDA Approval Newswire Kenvue Brands LLC has received FDA approval for IMODIUM Multi-Symptom Relief, an oral combination formulation of loperamide hydrochloride and dimethicone, …

FDA Fresenius Nov 6 — 0.00

FDA Approves VENOFER — Fresenius Medical Care Holdings, Inc.

# FDA Approves Fresenius Medical Care's Venofer for Intravenous Iron Supplementation Fresenius Medical Care Holdings, Inc. received FDA approval for Venofer (iron sucrose), an int…

FDA Meitheal Oct 25 — 0.00

FDA Approves LEUPROLIDE ACETATE — Meitheal Pharmaceuticals Inc

# FDA Approves Generic Leuprolide Acetate for Meitheal Pharmaceuticals Meitheal Pharmaceuticals Inc received FDA approval for its generic leuprolide acetate injection (ANDA075471)…

FDA Advagen Oct 6 — 0.00

FDA Approves CLONAZEPAM — Advagen Pharma Ltd

Advagen Pharma Ltd obtained FDA approval on October 6, 2000, for its generic oral Clonazepam tablet under ANDA075468. The clearance is expected to bolster Advagen’s earnings potent…

FDA SpecGx Sep 8 — 0.00

FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — SpecGx LLC

SpecGx LLC secured FDA approval for filing ANDA040405, gaining market access for generic HYDROCODONE BITARTRATE AND ACETAMINOPHEN. The entry of this generic alternative is expected…

FDA AbbVie Aug 4 — 0.00

FDA Approves DEPAKOTE ER — AbbVie Inc.

AbbVie Inc. solidified its foothold in the anticonvulsant market with the FDA approval of DEPAKOTE ER, the once-daily extended-release version of divalproex sodium, which is positi…

FDA Haleon Jul 25 — 0.00

FDA Approves ABREVA — Haleon US Holdings LLC

# FDA Approves Haleon's ABREVA (Docosanol) for Cold Sore Treatment Haleon US Holdings LLC has received FDA approval for ABREVA (docosanol), a topical antiviral treatment for cold …

FDA SANDOZ Jun 30 — 0.00

FDA Approves Unknown Drug — SANDOZ

Sandoz today received FDA approval for the unspecified substance designated under NDA020883 on June 30, 2000; although the specific therapeutic attribute remains unidentified in th…

FDA STRIDES May 31 — 0.00

FDA Approves Unknown Drug — STRIDES PHARMA INTL

STRIDES PHARMA INTL secured FDA approval for its generic submission, a milestone anticipated to intensify price competition and drive market share gains against branded incumbents.

FDA Pharmacia Apr 18 — 0.00

FDA Approves ZYVOX — Pharmacia & Upjohn Company LLC

**Pharmacia & Upjohn Company LLC** has secured FDA approval for its generic linezolid tablets, marking the first oral treatment for Staphylococcus aureus. This important clearance …

FDA Sun Mar 17 — 0.00

FDA Approves PENTAZOCINE AND NALOXONE — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. secured FDA approval for the generic version of PENTAZOCINE AND NALOXONE, a strategic addition anticipated to boost the company’s revenue potent…

FDA Mylan Feb 24 — 0.00

FDA Approves ESTRADIOL — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals received FDA approval for a transdermal estradiol patch, a move likely to intensify competitive pricing pressures and potentially erode the market share of br…

FDA Amici Feb 7 — 0.00

FDA Approves BUPROPION HYDROCHLORIDE — Amici Pharma, Inc.

Amici Pharma's approval of its bupropion hydrochloride generic is expected to intensify competition within the oral antidepressant market, pressuring the branded version's pricing …

FDA Hospira, Dec 17 — 0.00

FDA Approves PRECEDEX — Hospira, Inc.

# FDA Approves Hospira's PRECEDEX for Intravenous Administration Hospira, Inc. received FDA approval for PRECEDEX (dexmedetomidine hydrochloride), an intravenous sedative agent th…

FDA Cosette Aug 30 — 0.00

FDA Approves CLOMID — Cosette Pharmaceuticals, Inc.

# FDA Approves Clomiphene Citrate Generic for Cosette Pharmaceuticals Cosette Pharmaceuticals, Inc. received FDA approval for its generic version of Clomid (clomiphene citrate), a…